Global Sepsis Diagnostics Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2020 –2029 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 16.53 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球败血症诊断市场，按技术（免疫测定、分子诊断、微生物学和流式细胞术）、测试类型（实验室测试和护理点测试）划分的行业趋势和预测到 2029 年。
全球市场分析与洞察：全球败血症诊断市场
败血症是一种可能危及生命的疾病，当身体对感染的反应损害了自身组织时就会发生。当抗感染过程对身体起作用时，它们会导致器官功能不良和异常。败血症可能发展为感染性休克。这是一种血压急剧下降，可能导致严重的器官问题和死亡。要诊断败血症，必须通过精神状态、收缩压、呼吸频率等体征来确认感染。大多数情况下，败血症发生在住院患者或最近住院的患者身上。重症监护病房的患者更容易感染，然后导致败血症。为了诊断败血症，除了血液检查外，还需要进行其他实验室检查。血液样本用于检测感染、凝血问题、肝肾功能异常、氧气供应受损、电解质失衡的证据。败血症患者需要在医院重症监护病房接受密切监测和治疗。可能需要采取救生措施来稳定呼吸和心脏功能。
Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场将以 8.0% 的复合年增长率增长。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2019-2020（可定制为 2019 - 2014） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按技术（免疫测定、分子诊断、微生物学和流式细胞术）、检测类型（实验室检测和即时检测）分类 |
|
覆盖国家 |
北美的美国及北美其他地区、欧洲的德国、法国、英国及欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区的亚太其他地区 (APAC)、南美洲的巴西及南美洲其他地区。中东和非洲 (MEA) 的南非、沙特阿拉伯及中东和非洲 (MEA) 的其他地区。 |
|
涵盖的市场参与者 |
在市场上运营的主要公司有 Trinity Biotech（爱尔兰）、Meridian Bioscience（美国）、Omega Diagnostics Group PLC.（英国）、Xcyton Diagnostics Limited（印度）、Diasorin SpA（意大利）、Seegene Inc.（韩国）、EKF Diagnostics Holdings plc（英国）、Axis-Shield Diagnostics Ltd.（英国）、Immunexpress Inc.（美国）、Luminex Corporation（美国）、bioMérieux SA（法国）、BD（美国）、Thermo Fisher Scientific Inc.（美国）、Abbott（美国）、Roche Diagnostics（美国）、Cepheid（美国）、Beckman Coulter, Inc.（美国）、T2 Biosystems, Inc.（美国）、Bruker（美国）和 Ortho Clinical Diagnostics（美国）。 |
败血症诊断市场动态
驱动程序
- 医院内感染发病率上升
随着全球医院感染病例的快速增加，未来几年对合适的败血症诊断产品的需求也将增加。因此，医院感染发病率的上升预计将成为败血症诊断市场增长的推动力。
- 医疗支出上涨
影响败血症诊断市场增长率的另一个重要因素是医疗保健支出的增加，这有助于改善其基础设施。
- 败血症患病率不断上升
世界各地败血症患病率的不断上升以及与之相关的各种感染预计将成为败血症诊断市场增长的驱动力
此外，医疗技术的进步、公共和私人组织为传播意识而采取的举措不断增多以及政府资金的增加都是扩大败血症诊断市场的因素。
机会
- 脓毒症诊断新型生物标志物的演变
败血症是导致死亡和发病的主要原因之一，即使目前有广谱抗生素和先进的医疗手段。生物标记物可帮助早期诊断、识别并发症风险高的患者群体以及监测病情进展，而这些对于采取适当治疗措施和改善患者预后至关重要。
此外，有效疗法的推出和持续的临床试验将为 2022-2029 年预测期内败血症诊断市场提供有利机会。此外，当前治疗的巨大未满足需求和医疗技术的发展将在未来提高败血症诊断市场的增长率。
限制/挑战
然而，败血症诊断的高成本和缺乏适当的检测将阻碍败血症诊断市场的增长率。此外，对败血症缺乏认识将在上述预测期内进一步挑战市场。
本败血症诊断市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关败血症诊断市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
COVID-19 对败血症诊断市场的影响
COVID-19 对市场产生了负面影响。疫情期间的封锁和隔离使疾病管理和服药依从性变得复杂。无法获得医疗设施进行常规治疗和药物管理将进一步影响市场。社会隔离会增加压力、绝望和社会支持，所有这些都可能导致疫情期间败血症药物依从性的降低。
近期发展
- 2020 年 5 月，贝克曼库尔特宣布在美国推出其 DxH 690T 血液分析仪，该分析仪可用作早期败血症指标。这一公告有助于公司提高其全球影响力并增加收入。
全球败血症诊断市场范围
全球败血症诊断市场分为技术和检测类型。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
技术
- 免疫分析
- 分子诊断
- 微生物学
- 流式细胞术
根据技术，全球败血症诊断市场分为微生物学、分子诊断、免疫测定和流式细胞术。
测试类型
- 实验室测试
- 即时检验
根据测试类型，全球败血症诊断市场分为实验室测试和护理点测试。
败血症诊断市场区域分析/见解
对败血症诊断 市场进行了分析，并按上述国家、技术和测试类型提供了市场规模见解和趋势。
败血症诊断市场报告涵盖的国家 包括美国、北美其他地区、德国、英国、法国、欧洲其他地区、中国、印度、日本、韩国、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、亚太其他地区、巴西、南美洲其他地区、沙特阿拉伯、南非、中东和非洲其他地区。
北美 在市场份额和市场收入方面占据败血症诊断市场的主导地位，并将在预测期内继续保持主导地位。这是因为该地区拥有主要的关键参与者和发达的医疗保健基础设施，而且该地区每年被诊断为败血症的成年人口数量不断增加。另一方面，由于发展中国家政府的医疗保健支出不断增加以及政府支持力度不断加大，预计亚太地区在预测期内的增长率最高。
报告的国家部分还提供了影响单个市场因素和市场法规变化的信息，这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因本土和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。
竞争格局和败血症诊断市场份额分析
败血症诊断 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对败血症诊断 市场的关注有关。
败血症诊断市场的一些主要参与者 包括 Trinity Biotech（爱尔兰）、Meridian Bioscience、Omega Diagnostics Group PLC.、Xcyton Diagnostics Limited、Diasorin SpA、Seegene Inc.、EKF Diagnostics Holdings plc.、Axis-Shield Diagnostics Ltd.、Immunexpress Inc.、Luminex Corporation、bioMérieux SA、BD、Thermo Fisher Scientific Inc. Abbott、Roche Diagnostics、Cepheid、Beckman Coulter, Inc.、T2 Biosystems, Inc. 和 Bruker Ortho Clinical Diagnostics 等。
研究方法：全球败血症诊断市场
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域以及供应商份额分析。如有进一步询问，请要求分析师致电。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL SEPSIS DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TECHNIQUES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TECHNIQUES COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
5.1.2 RISE IN HEALTHCARE EXPENDITURE
5.1.3 GROW IN PREVALENCE OF SEPSIS
5.1.4 RISE IN TECHNOLOGICAL ADVANCEMENTS OF SEPSIS DIAGNOSTIC DEVICES
5.2 RESTRAINTS
5.2.1 HIGH COST OF DIAGNOSIS
5.2.2 LACK OF APPROPRIATE TESTING FOR SEPSIS
5.3 OPPORTUNITIES
5.3.1 DEVELOPMENT OF RAPID DIAGNOSTIC/POINT OF CARE (POC) TECHNIQUES FOR EARLY SEPSIS DIAGNOSIS
5.3.2 EVOLUTION OF NOVEL BIOMARKERS FOR SEPSIS DIAGNOSIS
5.4 CHALLENGES
5.4.1 LACK OF AWARENESS ABOUT SEPSIS
5.4.2 SHORTAGE OF SKILLED HEALTHCARE PROFESSIONALS
6 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES
6.1 OVERVIEW
6.2 IMMUNOASSAY
6.2.1 PROCALCITONIN (PCT)
6.2.2 INTERLEUKIN-6 (IL-6)
6.2.3 C-REACTIVE PROTEIN (CRP)
6.2.4 PENTRAXIN-3 (PTX3)
6.2.5 CALPROTECTIN
6.2.6 OTHERS
6.3 MOLECULAR DIAGNOSTIC
6.4 MICROBIOLOGY
6.5 FLOW CYTOMETRY
7 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE
7.1 OVERVIEW
7.2 LABORATORY TESTING
7.3 POINT OF CARE TESTING
8 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 OVERVIEW
8.2.2 U.S.
8.2.3 REST OF NORTH AMERICA
8.3 EUROPE
8.3.1 OVERVIEW
8.3.2 GERMANY
8.3.3 U.K.
8.3.4 FRANCE
8.3.5 REST OF EUROPE
8.4 ASIA-PACIFIC
8.4.1 OVERVIEW
8.4.2 CHINA
8.4.3 INDIA
8.4.4 JAPAN
8.4.5 SOUTH KOREA
8.4.6 AUSTRALIA
8.4.7 SINGAPORE
8.4.8 THAILAND
8.4.9 MALAYSIA
8.4.10 INDONESIA
8.4.11 PHILIPPINES
8.4.12 REST OF ASIA-PACIFIC
8.5 SOUTH AMERICA
8.5.1 OVERVIEW
8.5.2 BRAZIL
8.5.3 REST OF SOUTH AMERICA
8.6 MIDDLE EAST AND AFRICA
8.6.1 OVERVIEW
8.6.2 SOUTH AFRICA
8.6.3 SAUDI ARABIA
8.6.4 REST OF MIDDLE EAST AND AFRICA
9 GLOBAL SEPSIS DIAGNOSTICS MARKET: COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: GLOBAL
9.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
9.3 COMPANY SHARE ANALYSIS: EUROPE
9.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
10 COMPANY PROFILE
10.1 ROCHE DIAGNOSTICS
10.1.1 COMPANY SNAPSHOT
10.1.2 REVENUE ANALYSIS
10.1.3 COMPANY SHARE ANALYSIS
10.1.4 PRODUCT PORTFOLIO
10.1.5 RECENT DEVELOPMENT
10.2 ABBOTT.
10.2.1 COMPANY SNAPSHOT
10.2.2 REVENUE ANALYSIS
10.2.3 COMPANY SHARE ANALYSIS
10.2.4 PRODUCT PORTFOLIO
10.2.5 RECENT DEVELOPMENT
10.2.5.1 PRODUCT LAUNCH
10.3 BIOMERIEUX SA
10.3.1 COMPANY SNAPSHOT
10.3.2 REVENUE ANALYSIS
10.3.3 COMPANY SHARE ANALYSIS
10.3.4 PRODUCT PORTFOLIO
10.3.5 RECENT DEVELOPMENT
10.3.5.1 PRODUCT LAUNCH
10.4 THERMO FISHER SCINETIFIC INC.
10.4.1 COMPANY SNAPSHOT
10.4.2 REVENUE ANALYSIS
10.4.3 COMPANY SHARE ANALYSIS
10.4.4 PRODUCT PORTFOLIO
10.4.5 RECENT DEVELOPMENT
10.4.5.1 ACQUISITION
10.5 BD
10.5.1 COMPANY SNAPSHOT
10.5.2 REVENUS ANALYSIS
10.5.3 COMPANY SHARE ANALYSIS
10.5.4 PRODUCT PORTFOLIO
10.5.5 RECENT DEVELOPMENT
10.6 SEEGENE INC.
10.6.1 COMPANY SNAPSHOT
10.6.2 REVENUE ANALYSIS
10.6.3 PRODUCT PORTFOLIO
10.6.4 RECENT DEVELOPMENT
10.7 AXIS-SHIELD DIAGNOSTICS LTD.
10.7.1 COMPANY SNAPSHOT
10.7.2 PRODUCT PORTFOLIO
10.7.3 RECENT DEVELOPMENTS
10.8 BECKMAN COULTER, INC.
10.8.1 COMPANY SNAPSHOT
10.8.2 PRODUCT PORTFOLIO
10.8.3 RECENT DEVELOPMENTS
10.9 BRUKER
10.9.1 COMPANY SNAPSHOT
10.9.2 REVENUS ANALYSIS
10.9.3 PRODUCT PORTFOLIO
10.9.4 RECENT DEVELOPMENTS
10.1 CEPHEID
10.10.1 COMPANY SNAPSHOT
10.10.2 REVENUE ANALYSIS
10.10.3 PRODUCT PORTFOLIO
10.10.4 RECENT DEVELOPMENT
10.10.4.1 PROGRAM LAUNCH
10.11 DIASORIN S.P.A.
10.11.1 COMPANY SNAPSHOT
10.11.2 REVENUE ANALYSIS
10.11.3 PRODUCT PORTFOLIO
10.11.4 RECENT DEVELOPMENT
10.11.4.1 ACQUISITION
10.12 EKF DIAGNOSTICS HOLDINGS PLC
10.12.1 COMPANY SNAPSHOT
10.12.2 REVENUE ANALYSIS
10.12.3 PRODUCT PORTFOLIO
10.12.4 RECENT DEVELOPMENT
10.12.4.1 ACQUISITION
10.13 IMMUNEXPRESS INC.
10.13.1 COMPANY SNAPSHOT
10.13.2 PRODUCT PORTFOLIO
10.13.3 RECENT DEVELOPMENT
10.13.3.1 PRODUCT LAUNCH
10.14 LUMINEX CORPORATION.
10.14.1 COMPANY SNAPSHOT
10.14.2 PRODUCT PORTFOLIO
10.14.3 RECENT DEVELOPMENT
10.14.3.1 ACQUISITION
10.15 MERIDIAN BIOSCIENCE
10.15.1 COMPANY SNAPSHOT
10.15.2 REVENUS ANALYSIS
10.15.3 PRODUCT PORTFOLIO
10.15.4 RECENT DEVELOPMENTS
10.16 OMEGA DIAGNOSTICS GROUP PLC
10.16.1 COMPANY SNAPSHOT
10.16.2 REVENUE ANALYSIS
10.16.3 PRODUCT PORTFOLIO
10.16.4 RECENT DEVELOPMENT
10.17 ORTHO CLINICAL DIAGNOSTICS.
10.17.1 COMPANY SNAPSHOT
10.17.2 REVENUE ANALYSIS
10.17.3 PRODUCT PORTFOLIO
10.17.4 RECENT DEVELOPMENT
10.17.4.1 PRODUCT LAUNCH
10.18 T2 BIOSYSTEM, INC.
10.18.1 COMPANY SNAPSHOT
10.18.2 PRODUCT PORTFOLIO
10.18.3 RECENT DEVELOPMENT
10.18.3.1 PRODUCT LAUNCH
10.19 TRINITY BIOTECH
10.19.1 COMPANY SNAPSHOT
10.19.2 REVENUE ANALYSIS
10.19.3 PRODUCT PORTFOLIO
10.19.4 RECENT DEVELOPMENT
10.2 XCTON DAGNOSTICS LIMITED
10.20.1 COMPANY SNAPSHOT
10.20.2 PRODUCT PORTFOLIO
10.20.3 RECENT DEVELOPMENT
11 QUESTIONNAIRE
12 RELATED REPORTS
表格列表
TABLE 1 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 2 GLOBAL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)
TABLE 3 GLOBAL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 4 GLOBAL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 5 GLOBAL MOLECULAR DIAGNOSTICS IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)
TABLE 6 GLOBAL MICROBIOLOGY IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)
TABLE 7 GLOBAL FLOW CYTOMETRY IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)
TABLE 8 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 9 GLOBAL LABORATORY TESTING IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)
TABLE 10 GLOBAL POINT OF CARE TESTING IN SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)
TABLE 11 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019-2029 (USD MILLION)
TABLE 12 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)
TABLE 13 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 14 NORTH AMERICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 15 NORTH AMERICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 16 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 17 U.S. SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 18 U.S. IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 19 U.S. IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 20 U.S. SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 21 REST OF NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 22 EUROPE SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)
TABLE 23 EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 24 EUROPE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 25 EUROPE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 26 EUROPE SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 27 GERMANY SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 28 GERMANY IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 29 GERMANY IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 30 GERMANY SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 31 U.K. SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 32 U.K. IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 33 U.K. IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 34 U.K. SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 35 FRANCE SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 36 FRANCE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 37 FRANCE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 38 FRANCE SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 39 REST OF EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 40 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)
TABLE 41 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 42 ASIA-PACIFIC IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 43 ASIA-PACIFIC IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 44 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 45 CHINA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 46 CHINA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 47 CHINA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 48 CHINA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 49 INDIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 50 INDIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 51 INDIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 52 INDIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 53 JAPAN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 54 JAPAN IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 55 JAPAN IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 56 JAPAN SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 57 SOUTH KOREA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 58 SOUTH KOREA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 59 SOUTH KOREA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 60 SOUTH KOREA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 61 AUSTRALIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 62 AUSTRALIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 63 AUSTRALIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 64 AUSTRALIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 65 SINGAPORE SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 66 SINGAPORE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 67 SINGAPORE IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 68 SINGAPORE SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 69 THAILAND SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 70 THAILAND IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 71 THAILAND IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 72 THAILAND SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 73 MALAYSIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 74 MALAYSIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 75 MALAYSIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 76 MALAYSIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 77 INDONESIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 78 INDONESIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 79 INDONESIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 80 INDONESIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 81 PHILIPPINES SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 82 PHILIPPINES IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 83 PHILIPPINES IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 84 PHILIPPINES SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 85 REST OF ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 86 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)
TABLE 87 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 88 SOUTH AMERICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 89 SOUTH AMERICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 90 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 91 BRAZIL SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 92 BRAZIL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 93 BRAZIL IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 94 BRAZIL SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 95 REST OF SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 96 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2019-2029 (USD MILLION)
TABLE 97 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 98 MIDDLE EAST AND AFRICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 99 MIDDLE EAST AND AFRICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 100 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 101 SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 102 SOUTH AFRICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 103 SOUTH AFRICA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 104 SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 105 SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 106 SAUDI ARABIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
TABLE 107 SAUDI ARABIA IMMUNOASSAY IN SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (UNITS)
TABLE 108 SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019-2029 (USD MILLION)
TABLE 109 REST OF MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY TECHNIQUES, 2019-2029 (USD MILLION)
图片列表
FIGURE 1 GLOBAL SEPSIS DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 GLOBAL SEPSIS DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL SEPSIS DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL SEPSIS DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL SEPSIS DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL SEPSIS DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL SEPSIS DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL SEPSIS DIAGNOSTICS MARKET: MARKET TECHNIQUES COVERAGE GRID
FIGURE 9 GLOBAL SEPSIS DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL SEPSIS DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE GROWING PREVALENCE OF SEPSIS IS EXPECTED TO DRIVE THE GLOBAL SEPSIS DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 TECHNIQUES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL SEPSIS DIAGNOSTICS MARKET IN 2022 & 2029
FIGURE 13 NORTH AMERICA TO DOMINATE AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE GLOBAL SEPSIS DIAGNOSTICS MARKET FROM 2022 TO 2029
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR SEPSIS DIAGNOSTICS MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 15 DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGES FOR THE GLOBAL SEPSIS DIAGNOSTICS MARKET
FIGURE 16 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES, 2021
FIGURE 17 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES, 2022-2029 (USD MILLION)
FIGURE 18 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES, CAGR (2022-2029)
FIGURE 19 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES, LIFELINE CURVE
FIGURE 20 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TEST TYPE, 2021
FIGURE 21 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TEST TYPE, 2022-2029 (USD MILLION)
FIGURE 22 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2022-2029)
FIGURE 23 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 24 GLOBAL SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)
FIGURE 25 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY REGION (2021)
FIGURE 26 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY REGION (2022 & 2029)
FIGURE 27 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY REGION (2021 & 2029)
FIGURE 28 GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)
FIGURE 29 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)
FIGURE 30 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)
FIGURE 31 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 32 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 33 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)
FIGURE 34 EUROPE SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)
FIGURE 35 EUROPE SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)
FIGURE 36 EUROPE SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 37 EUROPE SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 38 EUROPE SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)
FIGURE 39 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)
FIGURE 40 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)
FIGURE 41 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 42 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 43 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)
FIGURE 44 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)
FIGURE 45 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)
FIGURE 46 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 47 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 48 SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)
FIGURE 49 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: SNAPSHOT (2021)
FIGURE 50 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021)
FIGURE 51 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 52 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 53 MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET: BY TECHNIQUES (2022-2029)
FIGURE 54 GLOBAL SEPSIS DIAGNOSTICS MARKET: COMPANY SHARE 2021 (%)
FIGURE 55 NORTH AMERICA SEPSIS DIAGNOSTICS MARKET: COMPANY SHARE 2021 (%)
FIGURE 56 EUROPE SEPSIS DIAGNOSTICS MARKET: COMPANY SHARE 2021 (%)
FIGURE 57 ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
